JP2020517272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517272A5 JP2020517272A5 JP2019557431A JP2019557431A JP2020517272A5 JP 2020517272 A5 JP2020517272 A5 JP 2020517272A5 JP 2019557431 A JP2019557431 A JP 2019557431A JP 2019557431 A JP2019557431 A JP 2019557431A JP 2020517272 A5 JP2020517272 A5 JP 2020517272A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinant phagemid
- genome
- particle
- particles
- expression cassette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 claims 48
- 230000014509 gene expression Effects 0.000 claims 21
- 108700019146 Transgenes Proteins 0.000 claims 18
- 102000004127 Cytokines Human genes 0.000 claims 17
- 108090000695 Cytokines Proteins 0.000 claims 17
- 150000007523 nucleic acids Chemical group 0.000 claims 15
- 238000004806 packaging method and process Methods 0.000 claims 11
- 241001515965 unidentified phage Species 0.000 claims 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
- 210000004881 tumor cell Anatomy 0.000 claims 9
- 108020004414 DNA Proteins 0.000 claims 8
- 102000053602 DNA Human genes 0.000 claims 8
- 108020004682 Single-Stranded DNA Proteins 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 230000010076 replication Effects 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 108090000172 Interleukin-15 Proteins 0.000 claims 4
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 4
- 101710172711 Structural protein Proteins 0.000 claims 4
- 210000000234 capsid Anatomy 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 108020005091 Replication Origin Proteins 0.000 claims 3
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 101710192393 Attachment protein G3P Proteins 0.000 claims 2
- 101710169873 Capsid protein G8P Proteins 0.000 claims 2
- 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 claims 2
- 102100037850 Interferon gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 108010065805 Interleukin-12 Proteins 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 108090000978 Interleukin-4 Proteins 0.000 claims 2
- 101710125418 Major capsid protein Proteins 0.000 claims 2
- 101710156564 Major tail protein Gp23 Proteins 0.000 claims 2
- 229920002873 Polyethylenimine Polymers 0.000 claims 2
- 108700012411 TNFSF10 Proteins 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 229920006317 cationic polymer Polymers 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 230000028327 secretion Effects 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 229920002491 Diethylaminoethyl-dextran Polymers 0.000 claims 1
- 241000255925 Diptera Species 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 241000713666 Lentivirus Species 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 101710193132 Pre-hexon-linking protein VIII Proteins 0.000 claims 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 230000006023 anti-tumor response Effects 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 208000028919 diffuse intrinsic pontine glioma Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000001125 extrusion Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1706451.0 | 2017-04-24 | ||
| GBGB1706451.0A GB201706451D0 (en) | 2017-04-24 | 2017-04-24 | Cancer treatment |
| PCT/GB2018/051070 WO2018197859A1 (en) | 2017-04-24 | 2018-04-24 | Cancer treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517272A JP2020517272A (ja) | 2020-06-18 |
| JP2020517272A5 true JP2020517272A5 (enExample) | 2021-07-29 |
| JP7671483B2 JP7671483B2 (ja) | 2025-05-02 |
Family
ID=58795775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019557431A Active JP7671483B2 (ja) | 2017-04-24 | 2018-04-24 | 癌の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11820792B2 (enExample) |
| EP (1) | EP3615562A1 (enExample) |
| JP (1) | JP7671483B2 (enExample) |
| CN (1) | CN110546253A (enExample) |
| CA (1) | CA3061422A1 (enExample) |
| GB (1) | GB201706451D0 (enExample) |
| WO (1) | WO2018197859A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101697473B1 (ko) | 2014-11-26 | 2017-01-18 | 주식회사 녹십자랩셀 | T 세포를 이용한 자연살해세포의 배양방법 |
| GB201519303D0 (en) | 2015-11-02 | 2015-12-16 | Imp Innovations Ltd | Phagemid vector |
| GB201706451D0 (en) | 2017-04-24 | 2017-06-07 | Imp Innovations Ltd | Cancer treatment |
| JP7039623B2 (ja) | 2017-05-26 | 2022-03-22 | グリーン・クロス・ラブ・セル・コーポレイション | 形質転換されたｔ細胞を用いてナチュラルキラー細胞を培養する方法 |
| AU2019381526B2 (en) | 2018-11-14 | 2023-02-23 | Green Cross Lab Cell Corporation | Method for culturing cord blood-derived natural killer cells using transformed T-cells |
| WO2022272296A2 (en) * | 2021-06-25 | 2022-12-29 | Homology Medicines, Inc. | Adeno-associated virus packaging systems |
| CN120958136A (zh) * | 2023-01-10 | 2025-11-14 | 帝国理工学院创新有限公司 | 噬菌体载体 |
| CN116790520A (zh) * | 2023-06-20 | 2023-09-22 | 扬州大学 | 一种可识别肿瘤表面的cea蛋白与表达3c蛋白的短链噬菌粒及其构建与应用 |
| CN116790521A (zh) * | 2023-06-20 | 2023-09-22 | 扬州大学 | 一种可识别肿瘤表面的cea蛋白与表达egfp蛋白的重组噬菌体及其构建与应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69129154T2 (de) * | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| JP2007504149A (ja) | 2003-08-26 | 2007-03-01 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 抗癌ワクチン |
| EP1960526A4 (en) | 2005-12-07 | 2009-07-15 | Los Alamos Nat Security Llc | PLASMIDES AND PACKAGING CELL LINES FOR USE IN A PHAG DISPLAY |
| CN101460055A (zh) * | 2006-04-07 | 2009-06-17 | 得克萨斯大学体系董事会 | 和腺伴随病毒-噬菌体颗粒相关的方法和组合物 |
| CN103038343A (zh) * | 2010-03-23 | 2013-04-10 | 英特瑞克斯顿股份有限公司 | 条件表达治疗蛋白的载体，包含所述载体的宿主细胞，及其应用 |
| GB201308745D0 (en) | 2013-05-15 | 2013-06-26 | Imp Innovations | Bacteriophage |
| GB201308742D0 (en) | 2013-05-15 | 2013-06-26 | Imp Innovations | Bacteriophage |
| US10030076B2 (en) * | 2014-01-07 | 2018-07-24 | Oklahoma Medical Research Foundation | Antibodies against glioma biomarkers |
| WO2017062953A1 (en) * | 2015-10-10 | 2017-04-13 | Intrexon Corporation | Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12 |
| GB201519303D0 (en) | 2015-11-02 | 2015-12-16 | Imp Innovations Ltd | Phagemid vector |
| GB201706451D0 (en) | 2017-04-24 | 2017-06-07 | Imp Innovations Ltd | Cancer treatment |
-
2017
- 2017-04-24 GB GBGB1706451.0A patent/GB201706451D0/en not_active Ceased
-
2018
- 2018-04-24 JP JP2019557431A patent/JP7671483B2/ja active Active
- 2018-04-24 WO PCT/GB2018/051070 patent/WO2018197859A1/en not_active Ceased
- 2018-04-24 EP EP18722706.1A patent/EP3615562A1/en active Pending
- 2018-04-24 US US16/607,653 patent/US11820792B2/en active Active
- 2018-04-24 CA CA3061422A patent/CA3061422A1/en active Pending
- 2018-04-24 CN CN201880025164.6A patent/CN110546253A/zh active Pending
-
2023
- 2023-09-22 US US18/472,764 patent/US20240101628A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517272A5 (enExample) | ||
| CN105307671B (zh) | 增强过继细胞疗法 | |
| US20220378822A1 (en) | Combinatorial cancer immunotherapy | |
| US20250170233A1 (en) | Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids | |
| JP2023524061A (ja) | 操作された中枢神経系用組成物 | |
| Ruiz et al. | MicroRNA-detargeted mengovirus for oncolytic virotherapy | |
| JP2019501661A5 (enExample) | ||
| JP2018533949A5 (enExample) | ||
| US12071633B2 (en) | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer | |
| WO2018228538A1 (zh) | 重组单纯疱疹病毒及其制备方法和应用 | |
| JP5943996B2 (ja) | 腫瘍溶解性強化Ｂ型ヒトアデノウイルスＡｄ１１突然変異体の構築とその応用 | |
| US20200017881A1 (en) | Programmable Oncolytic Virus Vaccine System and Method | |
| CA3110282A1 (en) | Fasl immunomodulatory gene therapy compositions and methods for use | |
| JP2021500070A5 (enExample) | ||
| CN102985094B (zh) | 一种重组肿瘤疫苗及其生产方法 | |
| Kobelt et al. | A brief introduction to current cancer gene therapy | |
| CN120513099A (zh) | 巨噬细胞特异性启动子和其用途 | |
| Goding et al. | Targeting of products of genes to tumor sites using adoptively transferred A-NK and T-LAK cells | |
| TW202448922A (zh) | 改良之ｅｒｔ２突變體、可誘導型細胞死亡系統及其用途 | |
| CN112011570A (zh) | 特异杀伤肿瘤细胞的溶瘤病毒系统及其应用 | |
| CA3106093C (en) | ANTI-TUMOR COMPOSITION | |
| CN115975946A (zh) | 表达趋化因子cxcl10、cxcl13、ccl19的免疫细胞及其制备方法与应用 | |
| CN112823209A (zh) | 使用编码高度紧凑的多输入逻辑门的核酸载体治疗疾病的方法 | |
| TW202509057A (zh) | 經修飾之降解決定子多肽及其用途 | |
| McDonald et al. | Royal Netherlands Academy of Arts and Sciences (KNAW) |